welcome to our

Investor Relations Portal

Welcome to our Investor Relations Portal! Here you can learn more about Protea’s game-changing bioanalytical technology, our management team, board of directors, science advisory board, as well as access SEC filings and other information resources.

Recent Releases Protea Announces First Quarter 2016 Results – Revenue increases 22% over Q1 2015 | PDF Version May 16, 2016 Protea announces license agreement with Yale | PDF Version Apr 25, 2016 New Potential Lung Cancer Biomarkers Identified | PDF Version Apr 19, 2016 Protea Announces 2015 Year End Results | PDF Version Mar 16, 2016 view all	BIO CEO & Investor Conference 2016 – Protea Presentation Click here to view.
Shareholder Report – Jan 2015 Click here to download	Upcoming Meetings Come See Us At: view all